Michael Shanler is on the Life Science CIO/Industry CIO team. He provides expert advice to life science clients (such as CIOs at pharmaceutical, biotech, medical device, CRO, CMO, CDMO, industrialized research centers and academic research hospitals), and can extend his coverage to other scientific formulated product development companies (e.g. specialty chemicals, nutraceutical, crop science, consumer goods, food and beverage, etc) . He has four major areas of coverage:
1- CxO digitalization business transformation and optimization. Discussions span executive vision, business capabilities, roadmaps, vendors and best practices. Typical engagements include delivering advice on digitalization, composable architecture, and delivering on new technology-centric capabilities.
2- R&D IT. He covers early stage product development including early research, drug discovery, research informatics (e.g. bioinformatics, cheminformatics), molecular modeling, and other forms of scientific IT. Pharma and biotech coverage spans from earliest stage product conceptualization up through pre-clinical / animal studies work. Michael also covers R&D NPI / NPD activities for medical device development and can extend coverage up until manufacturing.
3- Manufacturing IT. His coverage includes support models for biopharma manufacturing (e.g. MES, PLM, EBR, LIMS, QMS, etc.) for producing small molecule, large molecule and advanced therapeutics such as cell and gene therapies.
4- Laboratory Informatics and innovation. Michael covers digital lab of the future and has extensive knowledge of laboratory IT issues and applications such as Electronic Laboratory Notebook (ELN), Laboratory Information Management System (LIMS), Lab Execution System (LES), Chromatography Data System (CDS) and Scientific Data Management Systems (SMDS). Coverage extends across the entire value chain from early research, development testing, through QC in manufacturing.
Prior to joining Gartner, Mr. Shanler supervised an R&D engineering staff focused on new product development (NPD), technology development and continuous improvement activities. He drove new initiatives and assessed external technologies and acquisition candidates. He also has experience in developing strategic technology and product roadmaps; leading NPD programs and managing project teams (concept-launch) for consumables, reagents and instruments; managing innovation efforts for new product ideas; and driving global collaboration efforts.
Becton Dickinson, R&D Engineering Manager - New Product Innovation, 10 years
Pfizer, R&D Engineer/Scientist, 4 years
Healthcare and Life Science Digital Optimization and Modernization
Healthcare Provider, Payer and Life Science Industries Ecosystem
R&D Function Strategy and Management
B.S., Biomedical Engineering, Boston University
How to manage laboratory process and information
How to improve life science innovation processes within R&D in the digital era
How to leverage complex data in a life science company for accelerating innovation
How companies can achieve more effective collaboration for new product innovation (drug discovery & clinical development)
Setting R&D IT strategy and roadmaps